Nuo Therapeutics, Inc.
AURX
$1.50
$0.1259.09%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 6.44% | 1.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.44% | 1.70% | |||
| Cost of Revenue | -14.03% | 53.91% | |||
| Gross Profit | 14.09% | -9.69% | |||
| SG&A Expenses | 10.60% | 0.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.99% | 4.58% | |||
| Operating Income | -8.97% | -6.53% | |||
| Income Before Tax | 14.10% | -7.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.10% | -7.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.10% | -7.05% | |||
| EBIT | -8.97% | -6.53% | |||
| EBITDA | -7.73% | -6.54% | |||
| EPS Basic | 17.32% | -4.96% | |||
| Normalized Basic EPS | -6.33% | -3.95% | |||
| EPS Diluted | 17.32% | -4.96% | |||
| Normalized Diluted EPS | -6.33% | -3.95% | |||
| Average Basic Shares Outstanding | 3.42% | 2.14% | |||
| Average Diluted Shares Outstanding | 3.42% | 2.14% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||